Members |
targetComponentId |
Marburg virus |
Genus Marburgvirus (organism) |
Marburg virus disease |
Marburg virus disease |
Marginal zone lymphoma |
Marginal zone B-cell lymphoma |
Marijuana derivative |
Cannabinoid receptor agonist |
Marine crustacean - dietary |
Marine crustacean (substance) |
Marine dermatosis |
Disorder of skin (disorder) |
Marine mollusk - dietary |
Marine mollusk (substance) |
Marital maladjustment |
Maladjustment to married life |
Marital status of parents |
Marital status of parent |
Marlex patch |
Polypropylene mesh (physical object) |
Marsupialization of lesion of organ NOC |
Marsupialization |
Masculinism in girl |
Gender identity finding |
Mason fracture types |
Fracture configurations |
Mason type I fracture |
Mason type I fracture (morphologic abnormality) |
Mason type II fracture |
Mason type II fracture |
Mason type III fracture |
Mason type III fracture (morphologic abnormality) |
Masseur |
Massage therapist (occupation) |
Masseur |
Massage therapist (occupation) |
Mast cell leukemia |
Mast cell leukemia |
Mast cell malignancy of lymph nodes of axilla and upper limb |
Malignant mast cell tumor of lymph nodes of upper limb |
Mast cell malignancy of lymph nodes of inguinal region and lower limb |
Malignant mast cell tumor of lymph nodes of lower limb (disorder) |
Mastectomy NOS |
Excision of breast |
Mastectomy NOS |
Excision of breast |
Maternal 15q11q13 deletion |
Angelman syndrome due to maternal monosomy 15q11q13 (disorder) |
Maternal AND/OR fetal condition affecting labor AND/OR delivery |
Disorder of labor / delivery |
Maternal care for central nervous system malformation in fetus |
Central nervous system malformation in fetus affecting obstetrical care |
Maternal care for central nervous system malformation in fetus |
Central nervous system malformation in fetus affecting obstetrical care |
Maternal care for chromosomal abnormality in fetus |
Chromosomal abnormality in fetus affecting obstetrical care |
Maternal care for chromosomal abnormality in fetus |
Chromosomal abnormality in fetus affecting obstetrical care |
Maternal care for fetal abnormality and damage, unspecified |
Fetal condition affecting obstetrical care of mother |
Maternal care for fetal abnormality and damage, unspecified |
Fetal condition affecting obstetrical care of mother |
Maternal care for fetal acidosis during pregnancy |
Fetal acidemia affecting management of mother |
Maternal care for fetal acidosis during pregnancy |
Fetal acidemia affecting management of mother |
Maternal care for fetal bradycardia during pregnancy |
Fetal bradycardia affecting management of mother (disorder) |
Maternal care for fetal bradycardia during pregnancy |
Fetal bradycardia affecting management of mother (disorder) |
Maternal care for fetal decelerations during pregnancy |
Fetal distress affecting management of mother |
Maternal care for fetal decelerations during pregnancy |
Fetal distress affecting management of mother |
Maternal care for fetal tachycardia during pregnancy |
Fetal tachycardia affecting management of mother |
Maternal care for fetal tachycardia during pregnancy |
Fetal tachycardia affecting management of mother |
Maternal care for fetus |
Fetal condition affecting obstetrical care of mother |
Maternal care for poor fetal growth |
Poor fetal growth affecting management (disorder) |
Maternal care for poor fetal growth |
Poor fetal growth affecting management (disorder) |
Maternal care for suspected fetal abnormality and damage, unspecified |
Fetal condition affecting obstetrical care of mother |
Maternal care for suspected fetal abnormality and damage, unspecified |
Fetal condition affecting obstetrical care of mother |
Maternal care for viable fetus in abdominal pregnancy |
Fetal condition affecting obstetrical care of mother |
Maternal drug abuse |
Drug misuse by mother |
Maternal grandfather of subject |
Maternal grandfather |
Maternal grandmother of subject |
Maternal grandmother (person) |
Maternal labor/delivery problem NOS |
Disorder of labor / delivery |
Maternal labour/delivery problem NOS |
Disorder of labor / delivery |
Maternal pyrexia during labor, unspecified |
Disorder of labor / delivery |
Maxatase specific extract |
Product containing maxatase (medicinal product) |
Maxillary sinus TNM finding |
American Joint Committee on Cancer allowable value |
May Hegglin syndrome |
MYH9 related disease |
May-Hegglin anomaly |
MYH9 related disease |
May-Hegglin anomaly |
MYH9 related disease |
McCune-Albright syndrome |
Polyostotic fibrous dysplasia of bone |
Measles with other specified complications |
Measles with complication |
Measurement of Babesia equi antibody |
Measurement of Theileria equi antibody (procedure) |
Measurement of Bacillus anthracis antibody using direct fluorescence |
Measurement of Bacillus anthracis antigen using direct fluorescence (procedure) |
Measurement of antibody using direct fluorescence |
Direct tissue immunofluorescence procedure |
Measurement of blood toxic substance level |
Measurement of level of substance in blood (procedure) |
Mechanical complication due to breast prosthesis |
Mechanical complication of breast prosthesis |
Mechanical complication due to cystostomy catheter |
Mechanical complication of cystostomy catheter |
Mechanical complication due to heart valve prosthesis |
Mechanical complication of heart valve prosthesis |
Mechanical complication due to intrauterine contraceptive device |
Mechanical complication of intrauterine contraceptive device |
Mechanical complication due to ocular lens prosthesis |
Mechanical complication of intraocular lens |
Mechanical complication due to other implant or internal device, NOS |
Complication of surgical procedure |
Mechanical complication due to prosthetic reconstruction of vas deferens |
Mechanical complication of prosthetic reconstruction of vas deferens |
Mechanical complication of Hickman Line |
Mechanical complication of central venous catheter (disorder) |
Mechanical complication of cardiac device, implant AND/OR graft |
Mechanical complication of cardiovascular device |
Mechanical complication of cardiac device, implant and graft |
Mechanical complication of cardiovascular device |
Mechanical complication of other specified device, implant or graft |
Complication of surgical procedure |
Mechanical complication of other vascular device, implant or graft |
Mechanical complication of cardiovascular device |
Mechanical strabismus from other musculofascial disorder |
Mechanical strabismus due to musculofascial disorder |
Meclozine 12.5mg pastille |
Product containing precisely meclozine hydrochloride 12.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
Meclozine hydrochloride adverse reaction |
Adverse reaction to meclozine (disorder) |
MedDRA - SNOMED CT simple map reference set |
MedDRA to SNOMED CT simple map reference set (foundation metadata concept) |
Medial arm fasciocutaneous flap |
Fasciocutaneous flap |
Medial arm flap |
Flap (substance) |
Medial canthal ligament |
Structure of medial palpebral ligament |
Medial gastrocnemius flap |
Medial gastrocnemius muscle flap (substance) |
Medial lower leg fasciocutaneous flap |
Fasciocutaneous flap |
Medial lower leg flap |
Flap (substance) |
Medial plantar flap |
Medial plantar artery flap (substance) |
Medial thigh fasciocutaneous flap |
Fasciocutaneous flap |
Medial thigh flap |
Flap (substance) |
Mediastinoscopy - inspection only |
Mediastinoscopy |
Medical cardiovascular procedure |
Procedure on cardiovascular system |
Medical dermatologic procedure |
Procedure on integumentary system |
Medical procedure on heart |
Procedure on heart |
Medication dosage increase declined |
Medication dosage increase declined |
Medicinal gas |
Gaseous dose form |
Medicinal iodine |
Iodine |
Medicinal product acting as antigout agent (product) |
Uricosuric agent |
Medicinal product acting as antivenom (product) |
Product containing antivenom (product) |
Medicinal product containing mercury and/or mercury compound and acting as diuretic agent (product) |
Mercurial diuretic agent |
Medicinal product containing triazole and acting as antifungal agent (product) |
Triazole antifungal agent |
Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Medroxyprogesterone acetate 104mg injection suspension 0.65mL prefilled syringe |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
Medullary carcinoma with amyloid stroma |
Medullary carcinoma with amyloid stroma (morphologic abnormality) |